In a recent study, BMP2 has been shown to have pro-apoptotic effects on glioma-initiating cells by modulating the erythropoietin-producing hepatocellular carcinoma receptor A6 (EPHA6) (Raja et al., 2019[43]). This evidence concerns the gene EPHA6 and glioma.